https://www.cnbc.com/2018/11/01/gw-...s-drug-epidiolex-launch-in-united-states.html
Watch the full interview with the CEO of GW Pharma (scroll down) to consider the value that differentiates BOT as the first and only biotech running an FDA endorsed Phase2 trial on CBD in dermatology
.
https://www.cnbc.com/2018/11/01/gw-pharma-ceo-on-new-cannabis-dru...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 160000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11013 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
